 Harry Porterfield
Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Staphylococcal Infections | 2 | 2021 | 390 | 0.610 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 249 | 0.550 |
Why?
| | Mitral Valve Stenosis | 1 | 2015 | 20 | 0.450 |
Why?
| | Peanut Hypersensitivity | 4 | 2012 | 143 | 0.440 |
Why?
| | Glycoproteins | 4 | 2012 | 355 | 0.440 |
Why?
| | Mitral Valve | 1 | 2015 | 96 | 0.430 |
Why?
| | Arachis | 3 | 2012 | 108 | 0.410 |
Why?
| | Rheumatic Diseases | 1 | 2015 | 97 | 0.410 |
Why?
| | 2S Albumins, Plant | 4 | 2012 | 31 | 0.410 |
Why?
| | Cystic Fibrosis | 2 | 2021 | 1158 | 0.410 |
Why?
| | Antigens, Plant | 4 | 2012 | 55 | 0.400 |
Why?
| | Immunoglobulin E | 3 | 2009 | 315 | 0.370 |
Why?
| | Whole Genome Sequencing | 2 | 2025 | 183 | 0.360 |
Why?
| | Allergens | 3 | 2009 | 384 | 0.330 |
Why?
| | Achromobacter | 1 | 2025 | 1 | 0.230 |
Why?
| | Tandem Mass Spectrometry | 2 | 2024 | 577 | 0.220 |
Why?
| | Urine Specimen Collection | 1 | 2021 | 2 | 0.170 |
Why?
| | Heart Failure | 1 | 2015 | 2323 | 0.170 |
Why?
| | Urinalysis | 1 | 2021 | 80 | 0.170 |
Why?
| | Equipment Contamination | 1 | 2021 | 71 | 0.170 |
Why?
| | Trichomonas Vaginitis | 1 | 2019 | 3 | 0.150 |
Why?
| | Trichomonas vaginalis | 1 | 2019 | 11 | 0.150 |
Why?
| | Cervix Uteri | 1 | 2019 | 50 | 0.150 |
Why?
| | Aminopyridines | 1 | 2019 | 127 | 0.140 |
Why?
| | Benzodioxoles | 1 | 2019 | 158 | 0.130 |
Why?
| | Proteomics | 1 | 2024 | 1195 | 0.130 |
Why?
| | Pseudomonas Infections | 1 | 2019 | 221 | 0.130 |
Why?
| | Phylogeny | 1 | 2021 | 1019 | 0.120 |
Why?
| | Quinolones | 1 | 2019 | 201 | 0.120 |
Why?
| | Aminophenols | 1 | 2019 | 201 | 0.120 |
Why?
| | Algorithms | 1 | 2024 | 1839 | 0.120 |
Why?
| | Autopsy | 1 | 2015 | 94 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1915 | 0.100 |
Why?
| | Psychotic Disorders | 1 | 2015 | 186 | 0.090 |
Why?
| | Echocardiography | 1 | 2015 | 652 | 0.090 |
Why?
| | Electrophoresis, Gel, Two-Dimensional | 2 | 2009 | 110 | 0.090 |
Why?
| | Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2009 | 143 | 0.090 |
Why?
| | Desensitization, Immunologic | 1 | 2012 | 89 | 0.080 |
Why?
| | Anaphylaxis | 1 | 2012 | 102 | 0.080 |
Why?
| | Mast Cells | 2 | 2009 | 146 | 0.080 |
Why?
| | Plant Proteins | 2 | 2007 | 112 | 0.070 |
Why?
| | Chromatography, Gel | 1 | 2009 | 131 | 0.070 |
Why?
| | Chronic Disease | 1 | 2015 | 1813 | 0.070 |
Why?
| | Molecular Weight | 1 | 2009 | 327 | 0.070 |
Why?
| | Adolescent | 5 | 2021 | 22453 | 0.070 |
Why?
| | Immunoblotting | 1 | 2009 | 300 | 0.070 |
Why?
| | Chromatography, Liquid | 1 | 2009 | 454 | 0.060 |
Why?
| | Young Adult | 2 | 2021 | 14126 | 0.060 |
Why?
| | Humans | 11 | 2025 | 144957 | 0.060 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2025 | 51 | 0.050 |
Why?
| | Drug Resistance, Multiple, Bacterial | 1 | 2025 | 81 | 0.050 |
Why?
| | Basophils | 3 | 2012 | 52 | 0.050 |
Why?
| | Genome, Bacterial | 1 | 2025 | 156 | 0.050 |
Why?
| | Microbial Sensitivity Tests | 1 | 2025 | 371 | 0.050 |
Why?
| | Drug Resistance, Bacterial | 1 | 2025 | 199 | 0.050 |
Why?
| | Urination | 1 | 2021 | 48 | 0.040 |
Why?
| | Reproducibility of Results | 1 | 2009 | 3415 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2015 | 2584 | 0.040 |
Why?
| | Genotype | 1 | 2025 | 1835 | 0.040 |
Why?
| | Middle Aged | 4 | 2019 | 35928 | 0.040 |
Why?
| | Louisiana | 1 | 2019 | 28 | 0.040 |
Why?
| | Child, Preschool | 4 | 2021 | 11799 | 0.040 |
Why?
| | Female | 5 | 2021 | 78376 | 0.040 |
Why?
| | Drug Combinations | 1 | 2019 | 392 | 0.030 |
Why?
| | Workflow | 1 | 2019 | 185 | 0.030 |
Why?
| | Bacterial Proteins | 1 | 2024 | 962 | 0.030 |
Why?
| | Bacteria | 1 | 2024 | 889 | 0.030 |
Why?
| | Phenotype | 1 | 2025 | 3164 | 0.030 |
Why?
| | Pseudomonas aeruginosa | 1 | 2019 | 356 | 0.030 |
Why?
| | Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2019 | 370 | 0.030 |
Why?
| | Staphylococcus aureus | 1 | 2019 | 460 | 0.030 |
Why?
| | Child | 4 | 2021 | 22657 | 0.030 |
Why?
| | Retrospective Studies | 2 | 2025 | 17101 | 0.030 |
Why?
| | Tryptases | 1 | 2012 | 13 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2836 | 0.020 |
Why?
| | Histamine | 1 | 2012 | 53 | 0.020 |
Why?
| | Adult | 4 | 2019 | 40506 | 0.020 |
Why?
| | Mass Screening | 1 | 2019 | 1348 | 0.020 |
Why?
| | Basophil Degranulation Test | 1 | 2007 | 6 | 0.020 |
Why?
| | Male | 3 | 2021 | 72406 | 0.010 |
Why?
| | Immunochemistry | 1 | 2005 | 12 | 0.010 |
Why?
| | Plant Extracts | 1 | 2007 | 187 | 0.010 |
Why?
| | Biological Assay | 1 | 2005 | 128 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2012 | 4569 | 0.010 |
Why?
| | Membrane Proteins | 1 | 2005 | 1167 | 0.010 |
Why?
| | Rats | 1 | 2005 | 5614 | 0.010 |
Why?
| | Animals | 2 | 2012 | 38109 | 0.010 |
Why?
| | Mice | 1 | 2012 | 18365 | 0.010 |
Why?
| | Aged | 1 | 2007 | 25947 | 0.000 |
Why?
|
|
Porterfield's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|